4.7 Article

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Index60 as an additional diagnostic criterion for type 1 diabetes

Maria J. Redondo et al.

Summary: The study compared characteristics of individuals identified in the peri-diagnostic range by different glucose and C-peptide tests. Participants with high 2-hour glucose levels had older age, higher C-peptide responses, higher percentage of overweight/obesity, and lower multiple autoantibody positivity compared to those with high Index60 levels or both. Progression to diabetes was observed in participants with high glucose levels and/or high Index60 levels.

DIABETOLOGIA (2021)

Editorial Material Endocrinology & Metabolism

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Manuela Battaglia et al.

DIABETES CARE (2020)

Article Medicine, General & Internal

Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany

Anette-Gabriele Ziegler et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Endocrinology & Metabolism

Screening for type 1 diabetes: are we nearly there yet?

Parth Narendran

DIABETOLOGIA (2019)

Article Endocrinology & Metabolism

Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

Laura M. Jacobsen et al.

PEDIATRIC DIABETES (2019)

Article Medicine, Research & Experimental

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis

Carmella Evans-Molina et al.

JCI INSIGHT (2018)

Article Endocrinology & Metabolism

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials

Brandon M. Nathan et al.

DIABETES CARE (2017)

Review Immunology

Strategies for clinical trials in type 1 diabetes

Mario R. Ehlers

JOURNAL OF AUTOIMMUNITY (2016)

Article Endocrinology & Metabolism

Standards of Medical Care in Diabetes-2014

DIABETES CARE (2014)

Article Endocrinology & Metabolism

Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients

Katarzyna Siewko et al.

ENDOKRYNOLOGIA POLSKA (2014)

Article Medicine, General & Internal

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children

Anette G. Ziegler et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Medical Laboratory Technology

Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies

Jeffrey L. Mahon et al.

CLINICA CHIMICA ACTA (2011)

Article Endocrinology & Metabolism

Development of Autoantibodies in the TrialNet Natural History Study

Kendra Vehik et al.

DIABETES CARE (2011)

Article Endocrinology & Metabolism

Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network

Jay S. Skyler et al.

Immunology of Diabetes V: From Bench to Bedside (2008)

Article Endocrinology & Metabolism

Role of insulin resistance in predicting progression to type 1 diabetes

Ping Xu et al.

DIABETES CARE (2007)

Article Endocrinology & Metabolism

Insulin resistance is a risk factor for progression to Type 1 diabetes

S Fourlanos et al.

DIABETOLOGIA (2004)

Review Endocrinology & Metabolism

Use and abuse of HOMA modeling

TM Wallace et al.

DIABETES CARE (2004)

Article Endocrinology & Metabolism

IA-2 autoantibodies predict impending Type I diabetes in siblings of patients

K Decochez et al.

DIABETOLOGIA (2002)